Please ensure Javascript is enabled for purposes of website accessibility

Where Can You Find Good Dividends in Health Care?

By Brenton Flynn – Updated Apr 7, 2017 at 12:39PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In today's low-interest-rate environment, investors have flocked to dividend-paying stocks, which raises the question of where to go for nice yields in health care. Usually big pharma stocks are the best bet, but to find out for sure, Fool.com analyst Brenton Flynn conducted a screening in search of health-care companies yielding more than 3.5%. The results produced a grand total of 11 stocks -- out of the entire industry -- and pickings become even slimmer upon examination of these "winning" companies.

For instance, PDL BioPharma (PDLI)takes top place with its 7.8% yield, but considering that it loses patent protection in 2013 and 2014 and will continue to generate royalties only through 2016, this highest-yielding stock is one to run from -- not toward.

Watch the following video for Brenton's rundown on the rest of health care's top dividend-payers. There are several more to avoid, but also one small company that might just be the industry's unexpected best go-to for yield.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, and also reveal some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Brenton Flynn, Dave Williamson, and The Motley Fool have no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Novartis AG Stock Quote
Novartis AG
NVS
$76.52 (0.26%) $0.20
AstraZeneca PLC Stock Quote
AstraZeneca PLC
AZN
$9,933.00 (-1.42%) $-143.00
PDL BioPharma, Inc. Stock Quote
PDL BioPharma, Inc.
PDLI
Meridian Bioscience, Inc. Stock Quote
Meridian Bioscience, Inc.
VIVO
$31.92 (0.06%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
342%
 
S&P 500 Returns
107%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.